James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

GOOGL Stock: What to Know Before Alphabet Earnings

GOOGL stock is sure to move one way or another following this week's earnings results for Q3. In the long run, it is absolute growth, rather than met or missed expectations, that really matters.

Why Micron Technology, Inc. (MU), Harley-Davidson Inc (HOG) and Tesla Motors Inc (TSLA) Are 3 of Today’s Worst Stocks

Only the word "disastrous" accurately describes what happened to Micron Technology (MU), Harley-Davidson (HOG) and Tesla Motors (TSLA) on Tuesday.

BIIB Stock: What to Know Before Biogen Earnings

Down more than 40% since March, the fragile BIIB stock needs to deliver on its third-quarter earnings.

Why Morgan Stanley (MS), Freeport-McMoRan Inc. (FCX) and Valeant Pharmaceuticals Intl. Inc. (VRX) Are 3 of Today’s Worst Stocks

Too bad for owners of Morgan Stanley (MS), Freeport-McMoRan (FCX) and Valeant Pharmaceuticals (VRX) the market doesn't have do overs. Here's what investors need to know.

8 Hot Stocks That You Should Dump ASAP

Now's the time to typically be bullish, not looking for stocks to sell, but these eight hot stocks have good reason to be the exception to the Q4 norm.